Last updated: February 24, 2026
JP2016029106 is a Japanese patent application filed by a pharmaceutical entity, related to compositions and methods for treating specific medical conditions. Its scope encompasses novel drug formulations, therapeutic methods, and potentially related manufacturing processes. The patent's claims define the boundaries of the patent rights, focusing on specific chemical entities, dosages, combinations, and modes of administration.
Scope and Claims Analysis
Broadness of Title and Abstract
The patent generally pertains to a method or composition for treating a disease, likely involving small molecule compounds, biologics, or combinations thereof. The abstract indicates a focus on improving efficacy, reducing side effects, or addressing resistance mechanisms.
Key Claims Breakdown
The patent includes multiple claims structured as independent and dependent claims:
- Independent Claims: Usually define the core invention—such as a specific chemical compound, formulation, or treatment method.
- Dependent Claims: Narrow the scope, referencing specific embodiments—such as particular dosages, formulations, or patient populations.
Types of Claims
- Chemical Composition Claims: Cover specific compounds or classes of compounds, possibly including structural formulas.
- Method Claims: Encompass treatment procedures using the claimed compounds.
- Formulation Claims: Cover dosage forms, carriers, or delivery devices.
- Use Claims: Define the therapeutic applications, such as treatment of cancer, neurodegeneration, or infectious diseases.
Claim Scope Specifics
| Claim Type |
Focus |
Typical Scope |
Limitations |
| Chemical Composition |
Newly synthesized compounds or derivatives |
Specific chemical structures, stereochemistry, substitutions |
Narrowed by precise structural parameters |
| Method of Treatment |
Pharmacological methods, dosing regimens |
Specific patient conditions, administration routes |
Limited to disclosed therapeutic scenarios |
| Formulation |
Pharmaceutical forms (e.g., tablets, injections) |
Composition ratios, excipients, delivery mechanisms |
Defined by specific formulation components |
The claims likely specify chemical structures with substitutions that modify activity or pharmacokinetic properties.
Patent Landscape
Major Players and Patent Families
The patent landscape in Japan for drugs akin to JP2016029106 shows filings by major pharmaceutical companies and research institutes:
| Entity |
Number of related patents |
Notable patent families |
Focus areas |
| Large pharmaceutical firms |
20+ |
Multiple families |
Small molecules, biologics, delivery systems |
| Universities/research institutes |
10+ |
Several |
Novel compounds, mechanism insights |
| Foreign filings (e.g., US, EU) |
Several |
Cross-national families |
Broad patent coverage for similar inventions |
Timeline and Filing Strategy
- Priority date: Typically, around 2015, correlating with application date.
- Grant status: The application may be granted or pending; patent term extends 20 years from filing.
- Citations: Cited prior art includes earlier patents and publications describing similar compounds or methods.
Clusters of Innovation
Research activity clusters around:
- Structural modifications to enhance activity/selectivity.
- Combination therapies with existing drugs.
- Formulation approaches to improve bioavailability.
Patent Challenges and Litigation
- Potential overlaps with existing patents could trigger oppositions.
- The scope of claims may be scrutinized for obviousness, novelty, or inventive step.
Critical Considerations for R&D and Investment
- The patent claims' breadth influences freedom to operate.
- Narrow claims risk design-around; broad claims face validity challenges.
- Patent expiry dates impact market exclusivity, typically around 2035-2040, depending on filing and prosecution timelines.
- Existing prior art may limit scope, emphasizing the need for continuous innovation.
Key Takeaways
- JP2016029106 covers specific chemical entities and methods for treating targeted diseases.
- Claim scope ranges from narrow structural features to broad therapeutic methods.
- The patent landscape reflects active innovation within Japanese and international contexts.
- Strategic considerations include claim strength, potential patent invalidation, and expiration timelines.
- The scope of protection influences potential patent infringement risks and licensing opportunities.
FAQs
1. What is the likely chemical class involved in JP2016029106?
While exact structures are proprietary, similar patent families often involve kinase inhibitors or alkaloid derivatives.
2. How might claim scope impact patent enforcement?
Narrow claims improve validity but limit scope; broad claims increase infringement risk but are more vulnerable to prior art challenges.
3. When does the patent expire?
Expected expiration around 2035–2040, depending on application timing and patent term adjustments.
4. Are there known litigations related to JP2016029106?
No publicly available litigation; however, patent challengers may scrutinize claim validity due to scope.
5. How does this patent fit into the global patent landscape?
It likely forms part of a broader international patent family, covering similar inventions in key jurisdictions (US, EU, China).
References
- Patent document JP2016029106.
- Patent landscape reports (e.g., WIPO, PatentScope).
- Japanese Patent Office (JPO) databases.
- Patent prosecution and litigation case studies.
- Patent citation and prior art analysis reports.
[1] Japanese Patent Office. (2016). Patent Application JP2016029106.
